Baiyang Pharmaceutical: Progress Notice on Providing Guarantees for Subsidiaries
Baiyang Pharmaceutical: Announcement of Resolutions of the 24th Meeting of the Third Board of Directors
Baiyang Pharmaceutical: Announcement on not revising Baiyang\'s debt-for-share conversion price downward
Baiyang Pharmaceutical: Announcement on the progress of joint investment with professional investment institutions
Baiyang Pharmaceutical: An indicative announcement on the conditions expected to trigger a downward revision of Baiyang\'s debt-for-equity conversion price
Baiyang Pharmaceutical: Notice on completing the registration of industrial and commercial changes and issuing a business license
Baiyang Pharmaceutical: Announcement on changing the sponsor representative for continuous supervision
Baiyang Pharmaceutical: An indicative announcement on the conditions expected to trigger a downward revision of Baiyang\'s debt-for-equity conversion price
Baiyang Pharmaceutical: Progress Notice on Providing Guarantees for Subsidiaries
Baiyang Pharmaceutical: Announcement on partial share pledges by controlling shareholders and their co-actors
Baiyang Pharmaceutical: Announcement on the “Double Improvement of Quality and Return” action plan
Baiyang Pharmaceutical: Dongxing Securities Co., Ltd.\'s verification opinion on Qingdao Baiyang Pharmaceutical Co., Ltd. increasing the estimated amount of daily related transactions in 2024
Baiyang Pharmaceutical: Announcement of Board of Supervisory Committee Resolutions
Baiyang Pharmaceutical: Announcement on changes in accounting policies
Baiyang Pharmaceutical: Dongxing Securities Co., Ltd.\'s 2024 semi-annual continuous supervision and follow-up report on Qingdao Baiyang Pharmaceutical Co., Ltd.
Baiyang Pharmaceutical: 2024 Semi-Annual Report Summary
Baiyang Pharmaceutical: Summary table on the use of non-operating capital and other related capital transactions for the first half year of 2024
Baiyang Pharmaceutical: Announcement on increasing the estimated amount of daily related transactions in 2024
Baiyang Pharmaceutical: 2024 Semi-Annual Report
Baiyang Pharmaceutical: Announcement of Board Resolutions
No Data
No Data